A Prospective, Multicenter Trial to Explore the Efficacy and Safety of Obinutuzumab Adds on to Standard-of-care Therapy Consisting of Mycophenolate Mofetil (MMF) and Corticosteroids (O-triple) as Initial Therapy in the Active Lupus Nephritis Patients
Clinical trial NCT07767188 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07767188
- Sponsor
- Zhao Minghui
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-10
- Primary completion
- 2029-02-27
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.